Clinical Trials in New York

Showing 14801-14820 of 22,668 trials

Ultrasound to Detect Evidence for Retinal Detachment in Retinopathy of Prematurity

NCT00279669

Premature infants stand a risk of danger to the layer of the eye that creates sight that, if untreated, can cause severe vision problems, leading to blindness in some cases. This research study will use ultrasound to examine the eye for retinal changes of prematurity.

Retinopathy of Prematurity

Weill Medical College of Cornell University30 participantsStarted Dec 2004

New York, New York, United States

COMPLETED< 1 mile

PICU Transfusion Study: Harmful Effects of Red Blood Cell Transfusions

NCT02087553

The investigators hypothesize that the storage-damaged red cells are responsible for some of the adverse effects of transfusion. In this observational study, the investigators will measure various laboratory parameters both before and after transfusion in a pediatric intensive care unit to determine at what duration of storage is there laboratory evidence of refrigerator storage damage. The investigators hypothesize that increasing storage time of packed red blood cells (PRBCs) transfused will be associated with increasing non-transferrin-bound iron (NTBI), pro-inﬂammatory cytokine concentrations, and enhanced microbial growth in vitro in pediatric patients.

Iron, Abnormal Blood Level

Columbia University120 participantsStarted Dec 2013

New York, New York, United States • New York, New York, United States

TERMINATEDPhase 2< 1 mile

Safety and Efficacy of Simtuzumab (SIM, GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)

NCT01672866

The primary objective of this study is to evaluate whether SIM (formerly referred to as GS-6624) is effective at preventing the histologic progression of liver fibrosis and the clinical progression to cirrhosis in participants with NASH. It will consist of 2 phases: * Randomized Double-Blind Phase * Open-Label Phase (optional)

Liver Fibrosis Due to NASH

Gilead Sciences222 participantsStarted Dec 2012

Phoenix, Arizona, United States • Coronado, California, United States • San Diego, California, United States +65 more locations

Ultrasound to Detect Evidence for Retinal Detachment in Retinopathy of Prematurity

PICU Transfusion Study: Harmful Effects of Red Blood Cell Transfusions

Safety and Efficacy of Simtuzumab (SIM, GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)

Find Trials by Condition in New York

Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders

Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis

Closed Suction Drainage in Shoulder Arthroplasty

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of Long De Novo Coronary Artery Lesions (PLATINUM LL)

Proactive Outreach for Smokers in VA Mental Health

Enhancing Father's Ability to Support Their Preschool Child

Vitamin D Absorption in HIV Infected Young Adults Being Treated With Tenofovir Containing cART

Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction

Alternative Dosing Strategy of Ruxolitinib in Patients With Myelofibrosis

Study to Assess Analgesic Efficacy and Safety of ASP3662 in Subjects With Painful Diabetic Peripheral Neuropathy

Renal, Endocrine, and Bone Changes in Response to FTC/TDF in Uninfected Young Men Who Have Sex With Men (YMSM).

Safety & Efficacy Study of rAAV1-CB-hAAT for Alpha-1 Antitrypsin Deficiency

Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder

A Study of Sunitinib In Young Patients With Advanced Gastrointestinal Stromal Tumor

LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung Cancer

Open-label Extension Study to Assess Safety and Tolerability of LYC-30937-EC in Subjects With Active Ulcerative Colitis

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels